Future directions in the treatment of squamous cell carcinoma of the head and neck: The role of UFT

ONCOLOGY

Volumn 11, Issue 9 SUPPL. 10, 1997, Pages 86-89

  Dimitrios Colevas, A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BLEOMYCIN SULFATE; CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; PACLITAXEL; UFT;

CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONFERENCE PAPER; HEAD AND NECK CARCINOMA; HUMAN; ORAL DRUG ADMINISTRATION; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; DRUG COMBINATIONS; FORECASTING; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM STAGING; TEGAFUR; URACIL;

EID: 0030833024     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (3)

1. Forastiere A, Metch B, Schuller D, et al: Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil vs methotrexate in advanced squamous cell carcinoma of the head and neck: A Southwest Oncology Group Study. J Clin Oncol 10:1245-1251; 1992.
2. Ervin T, Weichselbaum R, Miller D, et al: Platinum, bleomycin, melhotrexate (P-B-M): A treatment for patients with advanced squamous cell carcinoma of the head and neck. Cancer Treat Rep 65:787-791, 1981.
3. DeConti R, Schoenfeld D: A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer. Cancer 48:1061-1072, 1981.